Publications by authors named "Greg Henkel"

Claim this Profile
P
pH-induced conformational changes and inhibition of the Lassa virus spike complex.
Michael Katz, Hadas Cohen-Dvashi, Sarah Borni, John Ruedas, Greg Henkel

Cell Host Microbe· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe mammarenaviral disease in guinea pigs effectively treated by an orally bioavailable fusion inhibitor, alone or in combination with favipiravir.
Jonna B Westover, Shibani Naik, Kevin W Bailey, Luci Wandersee, Vidyasagar R Gantla, Greg Henkel

Antiviral Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent inhibition of arenavirus infection by a novel fusion inhibitor.
Brian B Gowen, Shibani Naik, Jonna B Westover, Eric R Brown, Vidyasagar R Gantla, Greg Henkel

Antiviral Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel highly potent broad-spectrum heterocyclic chemical series of arenavirus cell entry inhibitors.
Michael B Plewe, Vidyasagar Reddy Gantla, Nadezda V Sokolova, Young-Jun Shin, Shibani Naik, Greg Henkel

Bioorg Med Chem Lett· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Adamantane Carboxamides as Ebola Virus Cell Entry and Glycoprotein Inhibitors.
Michael B Plewe, Nadezda V Sokolova, Vidyasagar Reddy Gantla, Eric R Brown, Shibani Naik, Greg Henkel

ACS Med Chem Lett· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SAR studies of 4-acyl-1,6-dialkylpiperazin-2-one arenavirus cell entry inhibitors.
Michael B Plewe, Landon R Whitby, Shibani Naik, Eric R Brown, Nadezda V Sokolova, Greg Henkel

Bioorg Med Chem Lett· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural analysis of H1N1 and H7N9 influenza A virus PA in the absence of PB1.
Spencer O Moen, Jan Abendroth, James W Fairman, Ruth O Baydo, Jameson Bullen, Greg Henkel

Sci Rep· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VX-322: a novel dual receptor tyrosine kinase inhibitor for the treatment of acute myelogenous leukemia.
David K Heidary, George Huang, Diane Boucher, Jianguo Ma, Cornelia Forster, Greg Henkel

J Med Chem· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and evaluation of a novel dual FMS-like tyrosine kinase 3/stem cell factor receptor (FLT3/c-KIT) inhibitor for the treatment of acute myelogenous leukemia.
Robert J Davies, Albert C Pierce, Cornelia Forster, Ron Grey, Jinwang Xu, Greg Henkel

J Med Chem· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-converting enzyme/caspase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients.
Jeffrey H Stack, Kevin Beaumont, Paul D Larsen, Kimberly S Straley, Greg W Henkel

J Immunol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis